EP Patent

EP2170062A4 — METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER, TUMORS AND TUMOR RELATED DISORDERS

Assigned to Adastra Pharmaceuticals Inc · Expires 2010-12-29 · 15y expired

What this patent protects

Patent listed against Dificid.

Drugs covered by this patent

Patent Metadata

Patent number
EP2170062A4
Jurisdiction
EP
Classification
—
Expires
2010-12-29
Drug substance claim
No
Drug product claim
No
Assignee
Adastra Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.